ロード中...
Topical Ranibizumab as a Treatment of Corneal Neovascularization
PURPOSE: To examine the effect of topical ranibizumab on clinically stable corneal neovascularization (NV). METHODS: This was a prospective, open-label, monocentric, uncontrolled, non-comparative study. Ten eyes of 9 patients with corneal NV received topical ranibizumab (1%) 4 times a day for 3 week...
保存先:
| 主要な著者: | , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3920979/ https://ncbi.nlm.nih.gov/pubmed/23407316 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/ICO.0b013e3182775f8d |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|